• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Gender difference in the mean age at the induction of hemodialysis in patients with autosomal dominant polycystic kidney disease.

作者信息

Ishikawa I, Maeda K, Nakai S, Kawaguchi Y

机构信息

Department of Internal Medicine, Division of Nephrology, Kanazawa Medical University, Uchinada, Japan.

出版信息

Am J Kidney Dis. 2000 Jun;35(6):1072-5. doi: 10.1016/s0272-6386(00)70042-4.

DOI:10.1016/s0272-6386(00)70042-4
PMID:10845819
Abstract

Male patients with autosomal dominant polycystic kidney disease (ADPKD) begin hemodialysis earlier than female patients. The rate of progression of many other renal diseases is also faster in men than women. In this study, gender difference in ADPKD was compared with that in other diseases, such as chronic glomerulonephritis, diabetic nephropathy, and nephrosclerosis, using the data obtained from an annual statistical survey of the Japanese Society for Dialysis Therapy. The male-female ratio in ADPKD (n = 8,176) was 1.17:1 and closer to 1.0:1 than the other diseases. Men with ADPKD started hemodialysis therapy 1.3 years earlier than women (male age, 55.9 +/- 12.4 years versus female age, 57.2 +/- 11.5 years), and the age difference was less than that in other diseases. These results suggest that the prognosis in women with ADPKD is relatively worse than that in men with ADPKD or that women are not well protected against the progression of this disease compared with other renal diseases. In conclusion, men with ADPKD are introduced to hemodialysis therapy earlier than women; however, the age difference was small compared with other common renal diseases.

摘要

相似文献

1
Gender difference in the mean age at the induction of hemodialysis in patients with autosomal dominant polycystic kidney disease.
Am J Kidney Dis. 2000 Jun;35(6):1072-5. doi: 10.1016/s0272-6386(00)70042-4.
2
Prevalence and renal prognosis of diagnosed autosomal dominant polycystic kidney disease in Japan.日本确诊的常染色体显性多囊肾病的患病率及肾脏预后
Nephron. 1998 Dec;80(4):421-7. doi: 10.1159/000045214.
3
Analysis of data from the ERA-EDTA Registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney disease.来自 ERA-EDTA 注册处的数据分析表明,针对常染色体显性遗传性多囊肾病的常规治疗并不能减少肾脏替代疗法的需求。
Kidney Int. 2014 Dec;86(6):1244-52. doi: 10.1038/ki.2014.120. Epub 2014 May 14.
4
Association between anemia and renal prognosis in autosomal dominant polycystic kidney disease: a retrospective study.常染色体显性多囊肾病患者贫血与肾脏预后的关系:一项回顾性研究。
Clin Exp Nephrol. 2020 Jun;24(6):500-508. doi: 10.1007/s10157-020-01856-1. Epub 2020 Feb 8.
5
Influence of the endothelial nitric oxide synthase polymorphism on the progression of autosomal dominant polycystic kidney disease and IgA nephropathy.内皮型一氧化氮合酶基因多态性对常染色体显性遗传性多囊肾病和IgA肾病进展的影响。
Ren Fail. 2002 Sep;24(5):585-93. doi: 10.1081/jdi-120013961.
6
Detection of autosomal dominant polycystic kidney disease by NMR spectroscopic fingerprinting of urine.尿液核磁共振谱指纹分析检测常染色体显性多囊肾病。
Kidney Int. 2011 Jun;79(11):1244-53. doi: 10.1038/ki.2011.30. Epub 2011 Mar 9.
7
Frequency and clinical profile of patients with polycystic kidney disease in southern Brazil.巴西南部多囊肾病患者的发病率及临床特征
Ren Fail. 2008;30(2):169-73. doi: 10.1080/08860220701810265.
8
[Study of prognostic factors for renal function in patients with autosomal dominant polycystic kidney disease].[常染色体显性多囊肾病患者肾功能预后因素的研究]
Nihon Hinyokika Gakkai Zasshi. 1994 Aug;85(8):1235-42. doi: 10.5980/jpnjurol1989.85.1235.
9
Peritoneal dialysis as a treatment option in autosomal dominant polycystic kidney disease.腹膜透析作为常染色体显性多囊肾病的一种治疗选择。
Int Urol Nephrol. 2015 Oct;47(10):1739-44. doi: 10.1007/s11255-015-1087-9. Epub 2015 Aug 19.
10
Influence of the endothelial nitric oxide synthase polymorphism on the progression of autosomal dominant polycystic kidney disease and IgA nephropathy.内皮型一氧化氮合酶基因多态性对常染色体显性多囊肾病和IgA肾病进展的影响。
Ren Fail. 2002 Jul;24(4):467-75. doi: 10.1081/jdi-120006773.

引用本文的文献

1
Empowering women at the heart of autosomal dominant polycystic kidney disease: Addressing unique challenges gender-sensitive approach.以常染色体显性多囊肾病为核心赋予女性力量:采用对性别敏感的方法应对独特挑战。
Womens Health (Lond). 2025 Jan-Dec;21:17455057251345944. doi: 10.1177/17455057251345944. Epub 2025 Jul 19.
2
DKK3 as a potential novel biomarker in patients with autosomal polycystic kidney disease.DKK3作为常染色体显性多囊肾病患者潜在的新型生物标志物。
Clin Kidney J. 2023 Oct 13;17(1):sfad262. doi: 10.1093/ckj/sfad262. eCollection 2024 Jan.
3
Molecular patterns of alpha-thalassemia in the kingdom of Saudi Arabia: identification of prevalent genotypes and regions with high incidence.
沙特阿拉伯王国α地中海贫血的分子模式:常见基因型和高发病率地区的鉴定。
Thromb J. 2023 Nov 10;21(1):115. doi: 10.1186/s12959-023-00560-w.
4
Conservative therapy is associated with worse clinical features and biochemical derangements than renal replacement therapy: a retrospective study in Kumasi, Ghana.与肾脏替代疗法相比,保守治疗与更差的临床特征和生化紊乱相关:加纳库马西的一项回顾性研究。
BMC Nephrol. 2022 Oct 26;23(1):343. doi: 10.1186/s12882-022-02951-z.
5
Demographic, diagnostic and therapeutic characteristics of autosomal dominant polycystic kidney disease in Ghana.加纳常染色体显性遗传性多囊肾病的人口统计学、诊断和治疗特征。
BMC Nephrol. 2021 Apr 28;22(1):156. doi: 10.1186/s12882-021-02336-8.
6
Improving kidney targeting: The influence of nanoparticle physicochemical properties on kidney interactions.提高肾脏靶向性:纳米颗粒物理化学性质对肾脏相互作用的影响。
J Control Release. 2021 Jun 10;334:127-137. doi: 10.1016/j.jconrel.2021.04.016. Epub 2021 Apr 20.
7
Considering Sex as a Biological Variable in Basic and Clinical Studies: An Endocrine Society Scientific Statement.将性别视为基础和临床研究中的生物学变量:内分泌学会科学声明。
Endocr Rev. 2021 May 25;42(3):219-258. doi: 10.1210/endrev/bnaa034.
8
The Biology of Vasopressin.血管加压素的生物学
Biomedicines. 2021 Jan 18;9(1):89. doi: 10.3390/biomedicines9010089.
9
Gender Differences in Non-sex Linked Disorders: Insights From Huntington's Disease.非性连锁疾病中的性别差异:来自亨廷顿舞蹈症的见解
Front Neurol. 2020 Jul 7;11:571. doi: 10.3389/fneur.2020.00571. eCollection 2020.
10
Characteristics of patients at initiation of renal replacement therapy - experience of a hemodialysis center.肾脏替代治疗开始时患者的特征——一家血液透析中心的经验
Exp Ther Med. 2020 Jul;20(1):103-108. doi: 10.3892/etm.2020.8608. Epub 2020 Mar 17.